These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 12692627

  • 1. Recombinant tissue plasminogen activator for treatment of hepatic veno-occlusive disease following bone marrow transplantation in children: effectiveness and a scoring system for initiating treatment.
    Bajwa RP, Cant AJ, Abinun M, Flood TJ, Hodges S, Hale JP, Skinner R.
    Bone Marrow Transplant; 2003 Apr; 31(7):591-7. PubMed ID: 12692627
    [Abstract] [Full Text] [Related]

  • 2. Recombinant tissue plasminogen activator (rtPA) for the treatment of hepatic veno-occlusive disease (VOD).
    Kulkarni S, Rodriguez M, Lafuente A, Mateos P, Mehta J, Singhal S, Saso R, Tait D, Treleaven JG, Powles RL.
    Bone Marrow Transplant; 1999 Apr; 23(8):803-7. PubMed ID: 10231143
    [Abstract] [Full Text] [Related]

  • 3. [Treatment of hepatic veno-occlusive disease after bone marrow transplantation with recombinant human tissue plasminogen activator (rh-tPA)].
    Yoshimi A, Kato K, Maeda N, Matsuyama T, Kojima S.
    Rinsho Ketsueki; 2000 Feb; 41(2):103-8. PubMed ID: 10723238
    [Abstract] [Full Text] [Related]

  • 4. Veno-occlusive disease of the liver complicating ABMT successfully treated with recombinant tissue plasminogen activator (rt-PA).
    Baglin TP, Harper P, Marcus RE.
    Bone Marrow Transplant; 1990 Jun; 5(6):439-41. PubMed ID: 2369685
    [Abstract] [Full Text] [Related]

  • 5. A review of tissue plasminogen activator in the treatment of veno-occlusive liver disease after bone marrow transplantation.
    Terra SG, Spitzer TR, Tsunoda SM.
    Pharmacotherapy; 1997 Jun; 17(5):929-37. PubMed ID: 9324182
    [Abstract] [Full Text] [Related]

  • 6. Recombinant human tissue plasminogen activator for the treatment of severe hepatic veno-occlusive disease in pediatric bone marrow transplant patients.
    Leahey AM, Bunin NJ.
    Bone Marrow Transplant; 1996 Jun; 17(6):1101-4. PubMed ID: 8807121
    [Abstract] [Full Text] [Related]

  • 7. No beneficial effects, but severe side effects caused by recombinant human tissue plasminogen activator for treatment of hepatic veno-occlusive disease after allogeneic bone marrow transplantation.
    Hägglund H, Ringdén O, Ljungman P, Winiarski J, Ericzon B, Tydén G.
    Transplant Proc; 1995 Dec; 27(6):3535. PubMed ID: 8540088
    [No Abstract] [Full Text] [Related]

  • 8. Fatal hemorrhage after recombinant tissue plasminogen activator therapy for hepatic veno-occlusive disease complicating autologous BMT.
    Otheo de Tejada E, Maldonado MS, Camarero C, Muñoz A.
    Bone Marrow Transplant; 1994 Jul; 14(1):176-7. PubMed ID: 7951113
    [No Abstract] [Full Text] [Related]

  • 9. Tissue plasminogen activator (tPA) as therapy for hepatotoxicity following bone marrow transplantation.
    Schriber J, Milk B, Shaw D, Christiansen N, Baer M, Slack J, Tezcan H, Wetzler M, Herzig G.
    Bone Marrow Transplant; 1999 Dec; 24(12):1311-4. PubMed ID: 10627640
    [Abstract] [Full Text] [Related]

  • 10. Recombinant tissue plasminogen activator (rTPA) for hepatic veno-occlusive disease after allogeneic BMT in a pediatric patient.
    Feldman L, Gabai E, Milovic V, Jaimovich G.
    Bone Marrow Transplant; 1995 Nov; 16(5):727. PubMed ID: 8547875
    [No Abstract] [Full Text] [Related]

  • 11. Risk factors for hepatic veno-occlusive disease after high-dose busulfan-containing regimens followed by autologous bone marrow transplantation: a study in 136 children.
    Méresse V, Hartmann O, Vassal G, Benhamou E, Valteau-Couanet D, Brugieres L, Lemerle J.
    Bone Marrow Transplant; 1992 Aug; 10(2):135-41. PubMed ID: 1525602
    [Abstract] [Full Text] [Related]

  • 12. [Veno-occlusive disease after bone marrow transplantation: preventive effect of heparin].
    Parquet N, Devergie A, Socié G, Ribaud P, Espérou H, Gluckman E.
    Ann Med Interne (Paris); 1997 Aug; 148(2):132-5. PubMed ID: 9238437
    [Abstract] [Full Text] [Related]

  • 13. Treatment of hepatic veno-occlusive disease with low-dose tissue plasminogen activator: impact on coagulation profile.
    Goldberg SL, Shubert J, Rao AK, Redei I, Klumpp TR, Mangan KF.
    Bone Marrow Transplant; 1996 Sep; 18(3):633-6. PubMed ID: 8879629
    [Abstract] [Full Text] [Related]

  • 14. [Efficacy of low-dose heparin and prostaglandin E1 in the prevention of hepatic veno-occlusive disease after allogenic hematopoietic stem cell transplantation in children with beta-thalassemia major].
    Sun X, Hao WG, Liu S, Xia T, Liao C.
    Zhongguo Dang Dai Er Ke Za Zhi; 2007 Aug; 9(4):343-6. PubMed ID: 17706036
    [Abstract] [Full Text] [Related]

  • 15. Successful treatment of veno-occlusive disease with recombinant tissue plasminogen activator in a patient requiring peritoneal dialysis.
    Simpson DR, Browett PJ, Doak PB, Palmer SJ.
    Bone Marrow Transplant; 1994 Oct; 14(4):635-6. PubMed ID: 7858540
    [Abstract] [Full Text] [Related]

  • 16. A prospective survey on incidence, risk factors and therapy of hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation.
    Cesaro S, Pillon M, Talenti E, Toffolutti T, Calore E, Tridello G, Strugo L, Destro R, Gazzola MV, Varotto S, Errigo G, Carli M, Zanesco L, Messina C.
    Haematologica; 2005 Oct; 90(10):1396-404. PubMed ID: 16219577
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Hepatic veno-occlusive disease after tranexamic acid administration in patients undergoing allogeneic hematopoietic stem cell transplantation.
    Mori T, Aisa Y, Shimizu T, Yamazaki R, Mihara A, Yajima T, Hibi T, Ikeda Y, Okamoto S.
    Am J Hematol; 2007 Sep; 82(9):838-9. PubMed ID: 17506069
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Association of hepatic veno-occlusive disease with interstitial pneumonitis in bone marrow transplant recipients.
    Wingard JR, Mellits ED, Jones RJ, Beschorner WE, Sostrin MB, Burns WH, Santos GW, Saral R.
    Bone Marrow Transplant; 1989 Nov; 4(6):685-9. PubMed ID: 2819287
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.